Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bixin Xi
Pharmacodynamics (PD) and Pharmacokinetics (PK) of E7389 (Eribulin, Halichondrin B Analog) During a Phase I Trial in Patients With Advanced Solid Tumors: A California Cancer Consortium Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Related publications
A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
O3-2-5a Phase I Trial of BI 754091, a Programmed Death Receptor 1 (PD-1) Inhibitor, in Patients With Advanced Solid Tumors
Annals of Oncology
Medicine
Oncology
Hematology
Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer Research
Oncology
A Phase I Trial of Vorinostat and Bortezomib in Children With Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL0916)
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Pharmacokinetics of Brequinar Sodium (NSC 368390) in Patients With Solid Tumors During a Phase I Study
European Journal of Cancer and Clinical Oncology
A Phase I Trial of UCN-01 and Prednisone in Patients With Refractory Solid Tumors and Lymphomas
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial
Urology
Urology
A Phase I Trial of MK-0731, a Kinesin Spindle Protein (KSP) Inhibitor, in Patients With Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
